These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8635012)

  • 1. New fears in gynecologic cancer.
    Smith PM; Schwartz PE
    Cancer; 1995 Nov; 76(10 Suppl):2133-7. PubMed ID: 8635012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A literature review of the social and psychological needs of ovarian cancer survivors.
    Roland KB; Rodriguez JL; Patterson JR; Trivers KF
    Psychooncology; 2013 Nov; 22(11):2408-18. PubMed ID: 23760742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological aspects of ovarian cancer.
    Hamilton AB
    Cancer Invest; 1999; 17(5):335-41. PubMed ID: 10370361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of Distress in Women with Ovarian Cancer.
    DellaRipa J; Conlon A; Lyon DE; Ameringer SA; Lynch Kelly D; Menzies V
    Oncol Nurs Forum; 2015 May; 42(3):292-300. PubMed ID: 25901381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological aspects of monitoring high risk women for breast cancer.
    Lynch HT; Lynch J; Conway T; Severin M
    Cancer; 1994 Aug; 74(3 Suppl):1184-92. PubMed ID: 8039155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
    McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
    Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social work role in an early ovarian cancer detection program.
    Smith PM; Schwartz PE
    Soc Work Health Care; 1993; 19(2):67-80. PubMed ID: 8153846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian women's perspectives on ovarian cancer.
    Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
    Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological impact of screening for familial ovarian cancer.
    Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
    J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of women's experiences of familial ovarian cancer screening.
    Lifford KJ; Clements A; Fraser L; Lancastle D; Brain K;
    Psychooncology; 2013 Nov; 22(11):2576-84. PubMed ID: 23801640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and ovarian cancer survivors' experience of participating in a cognitive-existential group intervention addressing fear of cancer recurrence.
    Maheu C; Lebel S; Tomei C; Singh M; Esplen MJ
    Eur J Oncol Nurs; 2015 Aug; 19(4):433-40. PubMed ID: 25555320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
    Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
    Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
    Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
    J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sword of Damocles cutting through the life stages of women with ovarian cancer.
    Cesario SK; Nelson LS; Broxson A; Cesario AL
    Oncol Nurs Forum; 2010 Sep; 37(5):609-17. PubMed ID: 20797952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
    Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
    Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.